世界の皮膚放射線傷害治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cutaneous Radiation Injury Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4082
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、100ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、皮膚放射線傷害治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、外用薬）、用途別市場規模（病院薬局、オンライン薬局、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・皮膚放射線傷害治療薬の市場動向
・企業の競争状況、市場シェア
・皮膚放射線傷害治療薬の種類別市場規模と予測2016-2027（経口薬、外用薬）
・皮膚放射線傷害治療薬の用途別市場規模と予測2016-2027（病院薬局、オンライン薬局、小売薬局）
・皮膚放射線傷害治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・皮膚放射線傷害治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・皮膚放射線傷害治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・皮膚放射線傷害治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・皮膚放射線傷害治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Merck、Novartis、Johnson & Johnson、Pfizer、Amgen、Roche、Eli Lily、AstraZeneca、Teva）
・結論

Cutaneous radiation injury occurs on a functional, cellular, and gross level. Radiation therapy is the major modality in the management of cancer treatment along with the surgery and chemotherapy. Most common side effect of the radiation is the acute skin reaction which usually range from mild to confluent moist desquamation.

Market Analysis and Insights: Global Cutaneous Radiation Injury Drug Market
The global Cutaneous Radiation Injury Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cutaneous Radiation Injury Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cutaneous Radiation Injury Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cutaneous Radiation Injury Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cutaneous Radiation Injury Drug market.

Global Cutaneous Radiation Injury Drug Scope and Market Size
Cutaneous Radiation Injury Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cutaneous Radiation Injury Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral Drug
Topical Drug

Segment by Application
Hospital Pharmacies
Online Pharnacies
Retail Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck
Novartis
Johnson & Johnson
Pfizer
Amgen
Roche
Eli Lily
AstraZeneca
Teva

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cutaneous Radiation Injury Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral Drug
1.2.3 Topical Drug
1.3 Market by Application
1.3.1 Global Cutaneous Radiation Injury Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Online Pharnacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cutaneous Radiation Injury Drug Market Perspective (2016-2027)
2.2 Cutaneous Radiation Injury Drug Growth Trends by Regions
2.2.1 Cutaneous Radiation Injury Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cutaneous Radiation Injury Drug Historic Market Share by Regions (2016-2021)
2.2.3 Cutaneous Radiation Injury Drug Forecasted Market Size by Regions (2022-2027)
2.3 Cutaneous Radiation Injury Drug Industry Dynamic
2.3.1 Cutaneous Radiation Injury Drug Market Trends
2.3.2 Cutaneous Radiation Injury Drug Market Drivers
2.3.3 Cutaneous Radiation Injury Drug Market Challenges
2.3.4 Cutaneous Radiation Injury Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cutaneous Radiation Injury Drug Players by Revenue
3.1.1 Global Top Cutaneous Radiation Injury Drug Players by Revenue (2016-2021)
3.1.2 Global Cutaneous Radiation Injury Drug Revenue Market Share by Players (2016-2021)
3.2 Global Cutaneous Radiation Injury Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cutaneous Radiation Injury Drug Revenue
3.4 Global Cutaneous Radiation Injury Drug Market Concentration Ratio
3.4.1 Global Cutaneous Radiation Injury Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cutaneous Radiation Injury Drug Revenue in 2020
3.5 Cutaneous Radiation Injury Drug Key Players Head office and Area Served
3.6 Key Players Cutaneous Radiation Injury Drug Product Solution and Service
3.7 Date of Enter into Cutaneous Radiation Injury Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cutaneous Radiation Injury Drug Breakdown Data by Type
4.1 Global Cutaneous Radiation Injury Drug Historic Market Size by Type (2016-2021)
4.2 Global Cutaneous Radiation Injury Drug Forecasted Market Size by Type (2022-2027)

5 Cutaneous Radiation Injury Drug Breakdown Data by Application
5.1 Global Cutaneous Radiation Injury Drug Historic Market Size by Application (2016-2021)
5.2 Global Cutaneous Radiation Injury Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cutaneous Radiation Injury Drug Market Size (2016-2027)
6.2 North America Cutaneous Radiation Injury Drug Market Size by Type
6.2.1 North America Cutaneous Radiation Injury Drug Market Size by Type (2016-2021)
6.2.2 North America Cutaneous Radiation Injury Drug Market Size by Type (2022-2027)
6.2.3 North America Cutaneous Radiation Injury Drug Market Size by Type (2016-2027)
6.3 North America Cutaneous Radiation Injury Drug Market Size by Application
6.3.1 North America Cutaneous Radiation Injury Drug Market Size by Application (2016-2021)
6.3.2 North America Cutaneous Radiation Injury Drug Market Size by Application (2022-2027)
6.3.3 North America Cutaneous Radiation Injury Drug Market Size by Application (2016-2027)
6.4 North America Cutaneous Radiation Injury Drug Market Size by Country
6.4.1 North America Cutaneous Radiation Injury Drug Market Size by Country (2016-2021)
6.4.2 North America Cutaneous Radiation Injury Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Cutaneous Radiation Injury Drug Market Size (2016-2027)
7.2 Europe Cutaneous Radiation Injury Drug Market Size by Type
7.2.1 Europe Cutaneous Radiation Injury Drug Market Size by Type (2016-2021)
7.2.2 Europe Cutaneous Radiation Injury Drug Market Size by Type (2022-2027)
7.2.3 Europe Cutaneous Radiation Injury Drug Market Size by Type (2016-2027)
7.3 Europe Cutaneous Radiation Injury Drug Market Size by Application
7.3.1 Europe Cutaneous Radiation Injury Drug Market Size by Application (2016-2021)
7.3.2 Europe Cutaneous Radiation Injury Drug Market Size by Application (2022-2027)
7.3.3 Europe Cutaneous Radiation Injury Drug Market Size by Application (2016-2027)
7.4 Europe Cutaneous Radiation Injury Drug Market Size by Country
7.4.1 Europe Cutaneous Radiation Injury Drug Market Size by Country (2016-2021)
7.4.2 Europe Cutaneous Radiation Injury Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cutaneous Radiation Injury Drug Market Size (2016-2027)
8.2 Asia-Pacific Cutaneous Radiation Injury Drug Market Size by Type
8.2.1 Asia-Pacific Cutaneous Radiation Injury Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cutaneous Radiation Injury Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cutaneous Radiation Injury Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Cutaneous Radiation Injury Drug Market Size by Application
8.3.1 Asia-Pacific Cutaneous Radiation Injury Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cutaneous Radiation Injury Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cutaneous Radiation Injury Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Cutaneous Radiation Injury Drug Market Size by Region
8.4.1 Asia-Pacific Cutaneous Radiation Injury Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cutaneous Radiation Injury Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cutaneous Radiation Injury Drug Market Size (2016-2027)
9.2 Latin America Cutaneous Radiation Injury Drug Market Size by Type
9.2.1 Latin America Cutaneous Radiation Injury Drug Market Size by Type (2016-2021)
9.2.2 Latin America Cutaneous Radiation Injury Drug Market Size by Type (2022-2027)
9.2.3 Latin America Cutaneous Radiation Injury Drug Market Size by Type (2016-2027)
9.3 Latin America Cutaneous Radiation Injury Drug Market Size by Application
9.3.1 Latin America Cutaneous Radiation Injury Drug Market Size by Application (2016-2021)
9.3.2 Latin America Cutaneous Radiation Injury Drug Market Size by Application (2022-2027)
9.3.3 Latin America Cutaneous Radiation Injury Drug Market Size by Application (2016-2027)
9.4 Latin America Cutaneous Radiation Injury Drug Market Size by Country
9.4.1 Latin America Cutaneous Radiation Injury Drug Market Size by Country (2016-2021)
9.4.2 Latin America Cutaneous Radiation Injury Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cutaneous Radiation Injury Drug Market Size (2016-2027)
10.2 Middle East & Africa Cutaneous Radiation Injury Drug Market Size by Type
10.2.1 Middle East & Africa Cutaneous Radiation Injury Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cutaneous Radiation Injury Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cutaneous Radiation Injury Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Cutaneous Radiation Injury Drug Market Size by Application
10.3.1 Middle East & Africa Cutaneous Radiation Injury Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cutaneous Radiation Injury Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cutaneous Radiation Injury Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Cutaneous Radiation Injury Drug Market Size by Country
10.4.1 Middle East & Africa Cutaneous Radiation Injury Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cutaneous Radiation Injury Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Cutaneous Radiation Injury Drug Introduction
11.1.4 Merck Revenue in Cutaneous Radiation Injury Drug Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Cutaneous Radiation Injury Drug Introduction
11.2.4 Novartis Revenue in Cutaneous Radiation Injury Drug Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Cutaneous Radiation Injury Drug Introduction
11.3.4 Johnson & Johnson Revenue in Cutaneous Radiation Injury Drug Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Cutaneous Radiation Injury Drug Introduction
11.4.4 Pfizer Revenue in Cutaneous Radiation Injury Drug Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Cutaneous Radiation Injury Drug Introduction
11.5.4 Amgen Revenue in Cutaneous Radiation Injury Drug Business (2016-2021)
11.5.5 Amgen Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Cutaneous Radiation Injury Drug Introduction
11.6.4 Roche Revenue in Cutaneous Radiation Injury Drug Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Eli Lily
11.7.1 Eli Lily Company Details
11.7.2 Eli Lily Business Overview
11.7.3 Eli Lily Cutaneous Radiation Injury Drug Introduction
11.7.4 Eli Lily Revenue in Cutaneous Radiation Injury Drug Business (2016-2021)
11.7.5 Eli Lily Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Cutaneous Radiation Injury Drug Introduction
11.8.4 AstraZeneca Revenue in Cutaneous Radiation Injury Drug Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 Teva
11.9.1 Teva Company Details
11.9.2 Teva Business Overview
11.9.3 Teva Cutaneous Radiation Injury Drug Introduction
11.9.4 Teva Revenue in Cutaneous Radiation Injury Drug Business (2016-2021)
11.9.5 Teva Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cutaneous Radiation Injury Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral Drug
Table 3. Key Players of Topical Drug
Table 4. Global Cutaneous Radiation Injury Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Cutaneous Radiation Injury Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cutaneous Radiation Injury Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Cutaneous Radiation Injury Drug Market Share by Regions (2016-2021)
Table 8. Global Cutaneous Radiation Injury Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Cutaneous Radiation Injury Drug Market Share by Regions (2022-2027)
Table 10. Cutaneous Radiation Injury Drug Market Trends
Table 11. Cutaneous Radiation Injury Drug Market Drivers
Table 12. Cutaneous Radiation Injury Drug Market Challenges
Table 13. Cutaneous Radiation Injury Drug Market Restraints
Table 14. Global Cutaneous Radiation Injury Drug Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Cutaneous Radiation Injury Drug Market Share by Players (2016-2021)
Table 16. Global Top Cutaneous Radiation Injury Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cutaneous Radiation Injury Drug as of 2020)
Table 17. Ranking of Global Top Cutaneous Radiation Injury Drug Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Cutaneous Radiation Injury Drug Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cutaneous Radiation Injury Drug Product Solution and Service
Table 21. Date of Enter into Cutaneous Radiation Injury Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cutaneous Radiation Injury Drug Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Cutaneous Radiation Injury Drug Revenue Market Share by Type (2016-2021)
Table 25. Global Cutaneous Radiation Injury Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Cutaneous Radiation Injury Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Cutaneous Radiation Injury Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Cutaneous Radiation Injury Drug Revenue Market Share by Application (2016-2021)
Table 29. Global Cutaneous Radiation Injury Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Cutaneous Radiation Injury Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Cutaneous Radiation Injury Drug Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Cutaneous Radiation Injury Drug Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Cutaneous Radiation Injury Drug Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Cutaneous Radiation Injury Drug Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Cutaneous Radiation Injury Drug Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Cutaneous Radiation Injury Drug Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Cutaneous Radiation Injury Drug Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Cutaneous Radiation Injury Drug Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Cutaneous Radiation Injury Drug Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Cutaneous Radiation Injury Drug Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Cutaneous Radiation Injury Drug Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Cutaneous Radiation Injury Drug Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Cutaneous Radiation Injury Drug Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Cutaneous Radiation Injury Drug Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cutaneous Radiation Injury Drug Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cutaneous Radiation Injury Drug Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cutaneous Radiation Injury Drug Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Cutaneous Radiation Injury Drug Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Cutaneous Radiation Injury Drug Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Cutaneous Radiation Injury Drug Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Cutaneous Radiation Injury Drug Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Cutaneous Radiation Injury Drug Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Cutaneous Radiation Injury Drug Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Cutaneous Radiation Injury Drug Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Cutaneous Radiation Injury Drug Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Cutaneous Radiation Injury Drug Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cutaneous Radiation Injury Drug Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cutaneous Radiation Injury Drug Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cutaneous Radiation Injury Drug Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Cutaneous Radiation Injury Drug Market Size by Country (2022-2027) & (US$ Million)
Table 61. Merck Company Details
Table 62. Merck Business Overview
Table 63. Merck Cutaneous Radiation Injury Drug Product
Table 64. Merck Revenue in Cutaneous Radiation Injury Drug Business (2016-2021) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Cutaneous Radiation Injury Drug Product
Table 69. Novartis Revenue in Cutaneous Radiation Injury Drug Business (2016-2021) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Johnson & Johnson Company Details
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Cutaneous Radiation Injury Drug Product
Table 74. Johnson & Johnson Revenue in Cutaneous Radiation Injury Drug Business (2016-2021) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Cutaneous Radiation Injury Drug Product
Table 79. Pfizer Revenue in Cutaneous Radiation Injury Drug Business (2016-2021) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Amgen Company Details
Table 82. Amgen Business Overview
Table 83. Amgen Cutaneous Radiation Injury Drug Product
Table 84. Amgen Revenue in Cutaneous Radiation Injury Drug Business (2016-2021) & (US$ Million)
Table 85. Amgen Recent Development
Table 86. Roche Company Details
Table 87. Roche Business Overview
Table 88. Roche Cutaneous Radiation Injury Drug Product
Table 89. Roche Revenue in Cutaneous Radiation Injury Drug Business (2016-2021) & (US$ Million)
Table 90. Roche Recent Development
Table 91. Eli Lily Company Details
Table 92. Eli Lily Business Overview
Table 93. Eli Lily Cutaneous Radiation Injury Drug Product
Table 94. Eli Lily Revenue in Cutaneous Radiation Injury Drug Business (2016-2021) & (US$ Million)
Table 95. Eli Lily Recent Development
Table 96. AstraZeneca Company Details
Table 97. AstraZeneca Business Overview
Table 98. AstraZeneca Revenue in Cutaneous Radiation Injury Drug Business (2016-2021) & (US$ Million)
Table 99. AstraZeneca Recent Development
Table 100. Teva Company Details
Table 101. Teva Business Overview
Table 102. Teva Cutaneous Radiation Injury Drug Product
Table 103. Teva Revenue in Cutaneous Radiation Injury Drug Business (2016-2021) & (US$ Million)
Table 104. Teva Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cutaneous Radiation Injury Drug Market Share by Type: 2020 VS 2027
Figure 2. Oral Drug Features
Figure 3. Topical Drug Features
Figure 4. Global Cutaneous Radiation Injury Drug Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Online Pharnacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Cutaneous Radiation Injury Drug Report Years Considered
Figure 9. Global Cutaneous Radiation Injury Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Cutaneous Radiation Injury Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Cutaneous Radiation Injury Drug Market Share by Regions: 2020 VS 2027
Figure 12. Global Cutaneous Radiation Injury Drug Market Share by Regions (2022-2027)
Figure 13. Global Cutaneous Radiation Injury Drug Market Share by Players in 2020
Figure 14. Global Top Cutaneous Radiation Injury Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cutaneous Radiation Injury Drug as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Cutaneous Radiation Injury Drug Revenue in 2020
Figure 16. Global Cutaneous Radiation Injury Drug Revenue Market Share by Type (2016-2021)
Figure 17. Global Cutaneous Radiation Injury Drug Revenue Market Share by Type (2022-2027)
Figure 18. North America Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Cutaneous Radiation Injury Drug Market Share by Type (2016-2027)
Figure 20. North America Cutaneous Radiation Injury Drug Market Share by Application (2016-2027)
Figure 21. North America Cutaneous Radiation Injury Drug Market Share by Country (2016-2027)
Figure 22. United States Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Cutaneous Radiation Injury Drug Market Share by Type (2016-2027)
Figure 26. Europe Cutaneous Radiation Injury Drug Market Share by Application (2016-2027)
Figure 27. Europe Cutaneous Radiation Injury Drug Market Share by Country (2016-2027)
Figure 28. Germany Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Cutaneous Radiation Injury Drug Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Cutaneous Radiation Injury Drug Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Cutaneous Radiation Injury Drug Market Share by Region (2016-2027)
Figure 38. China Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Cutaneous Radiation Injury Drug Market Share by Type (2016-2027)
Figure 46. Latin America Cutaneous Radiation Injury Drug Market Share by Application (2016-2027)
Figure 47. Latin America Cutaneous Radiation Injury Drug Market Share by Country (2016-2027)
Figure 48. Mexico Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Cutaneous Radiation Injury Drug Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Cutaneous Radiation Injury Drug Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Cutaneous Radiation Injury Drug Market Share by Country (2016-2027)
Figure 54. Turkey Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Cutaneous Radiation Injury Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Merck Revenue Growth Rate in Cutaneous Radiation Injury Drug Business (2016-2021)
Figure 58. Novartis Revenue Growth Rate in Cutaneous Radiation Injury Drug Business (2016-2021)
Figure 59. Johnson & Johnson Revenue Growth Rate in Cutaneous Radiation Injury Drug Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Cutaneous Radiation Injury Drug Business (2016-2021)
Figure 61. Amgen Revenue Growth Rate in Cutaneous Radiation Injury Drug Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Cutaneous Radiation Injury Drug Business (2016-2021)
Figure 63. Eli Lily Revenue Growth Rate in Cutaneous Radiation Injury Drug Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Cutaneous Radiation Injury Drug Business (2016-2021)
Figure 65. Teva Revenue Growth Rate in Cutaneous Radiation Injury Drug Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

世界の皮膚放射線障害治療市場規模・現状・予測（2021年-2027年）

Global Cutaneous Radiation Injury Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4083 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、皮膚放射線障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非ステロイド性抗炎症薬、抗ヒスタミン薬、抗生物質、コルチコステロイド、その他）、用途別市場規模（病院、診療所、外来外科センター、その他...

世界の皮膚B細胞リンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Cutaneous B-Cell Lymphoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4075 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、皮膚B細胞リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、モノクローナル抗体療法、その他）、用途別市場規模（病院、診療所、外来外科センター、その他）、主要地域別市場規...

世界のスニチニブ薬市場規模・現状・予測（2021年-2027年）

Global Sunitinib Drug Market Size, Status and Forecast 2021-2027
QFJ1-6026 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、スニチニブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（12.5mgカプセル、25mgカプセル、37.5mgカプセル、50mgカプセル）、用途別市場規模（腎臓がん、GIST、pNET）、主要地域別...

世界の圧力式外傷予防市場規模・現状・予測（2021年-2027年）

Global Pressure Injury Prevention Market Size, Status and Forecast 2021-2027
QFJ1-4761 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、圧力式外傷予防の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（マットレス、プロテクター、クッション、負荷軽減用履物、患者用ポジショナー）、用途別市場規模（病院、介護施設、在宅医療、外来手術センター）、...

世界の火傷治療市場規模・現状・予測（2021年-2027年）

Global Burn Injury Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3949 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、火傷治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（創傷被覆材、創傷被覆材、生物製品、医薬品、その他）、用途別市場規模（病院、診療所、在宅介護施設、その他）、主要地域別市場規模（北米、アメリカ、欧...

世界の診断用核医薬品市場規模・現状・予測（2021年-2027年）

Global Diagnostic Nuclear Drug Market Size, Status and Forecast 2021-2027
QFJ1-5703 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、診断用核医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Tc-99m、F-18、その他）、用途別市場規模（腫瘍学、心臓病学、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年）

Global Ambrisentan Drug Market Size, Status and Forecast 2021-2027
QFJ1-5574 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アンブリセンタン薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（5mg錠、10mg錠）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のマルチモダリティ放射線遮蔽用品市場規模・現状・予測（2021年-2027年）

Global Multimodality Radiation Shielding Market Size, Status and Forecast 2021-2027
QFJ1-5258 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、マルチモダリティ放射線遮蔽用品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（シールド、ブース、カーテン）、用途別市場規模（病院、クリニック、医療）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の向精神薬市場規模・現状・予測（2021年-2027年）

Global Psychotropic Drug Market Size, Status and Forecast 2021-2027
QFJ1-4785 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、向精神薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛薬、麻酔薬、催眠薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のパルボシクリブ薬市場規模・現状・予測（2021年-2027年）

Global Palbociclib Drug Market Size, Status and Forecast 2021-2027
QFJ1-5925 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、パルボシクリブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤タイプパルボシクリブ薬、カプセルタイプパルボシクリブ薬）、用途別市場規模（病院、診断センター、研究所）、主要地域別市場規模（北米、ア...

世界の皮膚放射線障害治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous Radiation Injury Treatment Market The global Cutaneous Radiation Injury Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and h…
世界の皮膚B細胞リンパ腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous B-Cell Lymphoma Treatment Market The global Cutaneous B-Cell Lymphoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and hig…
世界の向精神薬市場規模・現状・予測（2021年-2027年） The majority of essential psychotropic drugs are indicated to treat symptoms of mental disorders, slow down course of mental disorders, diminish disability and avoid relapse in a patient. Market Analysis and Insights: Global Psychotropic Drug Market The global Psychotropic Drug market size is projec…
世界のスニチニブ薬市場規模・現状・予測（2021年-2027年） Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…
世界のアテローム性動脈硬化症薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Atherosclerosis Drug Market The global Atherosclerosis Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…